Try our Advanced Search for more refined results
- Law360
- Law360 UK
- Law360 Pulse
- Law360 Employment Authority
- Law360 Tax Authority
- Law360 Insurance Authority
- Law360 Real Estate Authority
- Law360 Healthcare Authority
- Law360 Bankruptcy Authority
- Products
- Lexis®
- Law360 In-Depth
- Law360 Podcasts
- Rankings
- Regional Powerhouses
- Law360's MVPs
- Women in Law Report
- Law360 400
- Diversity Snapshot
- Practice Groups of the Year
- Rising Stars
- Titans of the Plaintiffs Bar
- Sections
- Adv. Search & Platform Tools
- About all sections
- Browse all sections
- Banking
- Bankruptcy
- Class Action
- Competition
- Employment
- Energy
- Expert Analysis
- Insurance
- Intellectual Property
- Product Liability
- Securities
- Beta Tools
- Track docs
- Track attorneys
- Track judges
EISAI INC. v. SANOFI-AVENTIS U.S., LLC et al
Case Number:
3:08-cv-04168
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
-
April 07, 2014
Sanofi Escapes Antitrust Suit Over Lovenox Contracts
Nixing an antitrust suit brought by Eisai Inc., a New Jersey federal judge ruled that Sanofi-Aventis US LLC did not violate federal law by entering into discount contracts with hospitals that purchased large amounts of its anticoagulant drug Lovenox, according to an opinion unsealed on Friday.
-
June 07, 2013
Eisai Destroyed Evidence In Antitrust Case, Sanofi Says
Eisai Inc. destroyed evidence and should face sanctions in its case alleging that Sanofi-Aventis US LLC used supply contracts for the anti-coagulant Lovenox to harm competition, Sanofi told a New Jersey federal court in a filing made public Thursday.
-
March 16, 2012
Eisai Says Sanofi Misled Court In Feud Over Deposition Docs
Japanese pharmaceutical company Eisai Inc. lodged an appeal Friday of a magistrate judge's ruling that it couldn't make Sanofi-Aventis US LLC produce deposition transcripts from a 2003 antitrust suit, arguing Sanofi misled the court by claiming the old suit involved different parties and another drug, contract and market.
-
February 28, 2012
Eisai Can't Pry Transcripts From 2003 Aventis Antitrust Suit
A New Jersey federal judge on Monday ruled that Eisai Inc. cannot compel Sanofi-Aventis US LLC to produce the deposition transcripts of witnesses who gave testimony in a 2003 antitrust suit, holding the depositions are irrelevant to the current case over Sanofi's alleged hold on the anti-coagulant market.